Apelin protects against acute renal injury by inhibiting TGF-β1

Hong Chen1, Danyang Wan2, Lin Wang2

  • 1Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, China, 430030; Centre for Biomedicine Research, Wuhan Institute of Biotechnology, Wuhan, China, 430074.

Insights

Apelin-13 peptide effectively protects against acute kidney injury caused by renal ischemia/reperfusion (I/R). This treatment reduces kidney damage, inflammation, and cell death, suggesting its therapeutic potential.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Renal ischemia/reperfusion (I/R) injury is a primary cause of acute kidney injury (AKI) with high mortality.
  • Current therapies for AKI lack effectiveness.
  • Apelin-13, a bioactive peptide, has demonstrated protective effects in diabetic nephropathy models.

Purpose of the Study:

  • To investigate the protective effects of apelin-13 against renal I/R injury in a rat model.
  • To explore the molecular mechanisms underlying apelin-13's renoprotective actions.

Main Methods:

  • Male rats were subjected to renal I/R injury with or without apelin-13 treatment.
  • In vitro studies utilized cultured renal mesangial and tubular cells exposed to hypoxia/reperfusion (H/R).
  • Assessed tubular lesions, apoptosis, renal dysfunction, inflammatory factors, TGF-β1, histone methylation (H3K4me2), and Kmt2d expression.

Main Results:

  • Apelin-13 treatment significantly reduced tubular lesions, renal cell apoptosis, and normalized renal dysfunction post-I/R.
  • Apelin-13 inhibited the elevation of inflammatory factors, TGF-β1, and apoptosis induced by I/R.
  • Apelin-13 suppressed I/R-induced increases in histone methylation (H3K4me2) and Kmt2d in vivo and in vitro.

Conclusions:

  • Apelin-13 demonstrates significant renoprotective effects against I/R injury by mitigating inflammation and apoptosis.
  • The mechanism involves the inhibition of TGF-β1 and aberrant histone methylation.
  • Apelin-13 presents a promising therapeutic candidate for acute kidney injury.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
518
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
502
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.3K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K